ST

Sharma Truptiben Vikaskumar

Active Director Designated Partner DIN 11126501
DIN 11126501 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sharma Truptiben Vikaskumar

Data last updated:

Sharma Truptiben Vikaskumar is a Designated Partner at Aej Pharmaceutical Llp (since 2025).

DIN 11126501
Primary Designation Designated Partner
First Appointment 27 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 May 20252025Active

Board colleagues of Sharma Truptiben Vikaskumar

NameDINCompanyDesignation
Dipikaben Nai11126502Aej Pharmaceutical LlpDesignated Partner
Sarojben Rameshbhai Patel11126503Aej Pharmaceutical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Aej Pharmaceutical Llp
Premium access

Shareholding and investment profile for Sharma Truptiben Vikaskumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharma Truptiben Vikaskumar

Sharma Truptiben Vikaskumar currently holds 1 directorship: Aej Pharmaceutical Llp (Designated Partner, since 27 May 2025).

Sharma Truptiben Vikaskumar was first appointed on 27 May 2025 as Designated Partner at Aej Pharmaceutical Llp.

The current boards of Sharma Truptiben Vikaskumar's companies include Dipikaben Nai (Aej Pharmaceutical Llp), Sarojben Rameshbhai Patel (Aej Pharmaceutical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available